Colin M. Young
- Accounting top 5%
- Economics and Econometrics top 5%
- Finance top 5%
- Strategy and Management top 10%
- Oncology
- Co-authors
- Edward I. AltmanMarti G. SubrahmanyamCasey QuinnMark TrusheimRichard A. BrealeyNikola A. IvicaJonathan C. ThomasJonathan Salcedo
- Topics
- Health Systems, Economic Evaluations, Quality of Life (4 papers)Pharmaceutical Economics and Policy (4 papers)Innovation Policy and R&D (3 papers)
- Partner nations
- United StatesNetherlands
In The Last Decade
Colin M. Young
11 papers receiving 423 citations
Peers
Comparison fields: 5 of 65
- Accounting 207
- Economics and Econometrics 206
- Finance 182
- Strategy and Management 139
- Oncology 54
Countries citing papers authored by Colin M. Young
This map shows the geographic impact of Colin M. Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin M. Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin M. Young more than expected).
Fields of papers citing papers by Colin M. Young
This network shows the impact of papers produced by Colin M. Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin M. Young. The network helps show where Colin M. Young may publish in the future.
Co-authorship network of co-authors of Colin M. Young
This figure shows the co-authorship network connecting the top 25 collaborators of Colin M. Young. A scholar is included among the top collaborators of Colin M. Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin M. Young. Colin M. Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 23 | |
| 4 | 33 | |
| 5 | 28 | |
| 6 | 4 | |
| 7 | 51 | |
| 8 | Biotech injectable drugs: clinical applications and financial effects. | 2 |
| 9 | 0 | |
| 10 | 13 | |
| 11 | 284 | |
| 12 | 1 | |
| 13 | 1 | |
| 14 | 46 |
About Colin M. Young
Colin M. Young is a scholar working on Economics and Econometrics, Finance and Genetics, having authored 14 papers that have together received 488 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (4 papers), Pharmaceutical Economics and Policy (4 papers) and Innovation Policy and R&D (3 papers). The work is most often cited by research in Accounting (207 citations), Finance (182 citations) and Strategy and Management (139 citations). Colin M. Young has collaborated with scholars based in United States and Netherlands. Frequent co-authors include Edward I. Altman, Marti G. Subrahmanyam, Casey Quinn, Mark Trusheim, Richard A. Brealey, Nikola A. Ivica, Jonathan C. Thomas, Jonathan Salcedo, Carl B. McGowan and Annie Kennedy. Their work appears in journals such as The Journal of Finance, Blood and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.